BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric pentadecapeptide that promotes angiogenesis through VEGF upregulation and protects tissue through nitric oxide system modulation
It is important not to stop or delay evidence-based DMARD or biologic therapy in favour of experimental GLP-1 therapy outside a clinical trial
Administered in-clinic by our licensed Naturopathic Doctors, theyre safe, fast, and tailored to your needs
438 Complete abstinence from alcohol enhances prognosis, mitigates liver histological injury, decreases portal vein pressure, delays fibrosis progression, and improves survival at all stages of the disease
This timeframe applies to opened vials and pre-filled pens that have been punctured or activated
GLP-1 receptor agonists are medications (such as semaglutide, tirzepatide, and liraglutide) that mimic a natural gut hormone, helping lower blood sugar, reduce appetite, promote weight loss, and decrease inflammation. Can GLP-1 medications help with both diabetes and weight loss